The global cold plasma market size is expected to reach USD 495.9 million by 2033, registering a CAGR of 14.6% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing use of cold plasma in medical treatment and rising cases of Hospital-Acquired Infections (HAI) are the key driving factors for the global market. In healthcare industry, plasma technology has been in use for some time and it continues to help improve various treatments. One of the major properties of cold plasma is the ability to kill bacteria and prevent infection. Therefore, it acts as an effective healing solution. It also accelerates healing process and prevent patient from discomfort.
Cold plasma is used in the treatment of chronic wounds and burns. The bacterial cells, including Multidrug Resistant (MDR) bacteria, are instantly killed after being exposed to cold plasma. As per an article published by the Medical Xpress, Med Tech Europe, around 4.0 million people in Europe suffer from non-healing wounds every year. It also reported that a burn patient in Germany was treated using prototype plasma treatment. Moreover, as per a research published by The National Center for Biotechnology Information (NCBI), a patient suffering with two second-degree burns was treated with cold plasma, which healed the itching and pain and presented new tissue after the second treatment. Such cases are anticipated to promote the usage of cold plasma in various wound treatments.
Request a free sample copy or view report summary: Cold Plasma Market Report
The atmospheric pressure cold plasma segment led the market and accounted for the largest revenue share of 63.7% in 2025. This growth is driven by its versatile applications in wound care, sterilization, and infection control.
The wound healing application segment dominated the market and accounted for the largest revenue share of 35.3% in 2025. This growth is attributed to the development of wound healing effects in patients due to the usage of this technology, which includes faster tissue generation, reduced infection risks, and better overall outcomes.
The North America cold plasma market dominated the global market and accounted for the largest revenue share of 40.4% in 2025. This growth is attributed to technological advancements in the industry's products and innovations.
Grand View Research has segmented the global cold plasma market based on pressure, application, and region:
Cold Plasma Pressure Outlook (Revenue, USD Million, 2021 - 2033)
Low-Pressure Cold Plasma
Atmospheric Pressure Cold Plasma
Cold Plasma Application Outlook (Revenue, USD Million, 2021 - 2033)
Wound Healing
Blood Coagulation
Dentistry
Cancer Treatment
Other Medical Applications
Cold Plasma Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Kuwait
List Of Key Players Cold Plasma Market
Apyx Medical
neoplas med GmbH
Adtec Healthcare Limited
terraplasma GmbH
CINOGY System GmbH
Plasmacure
relyon plasma GmbH
US Medical Innovations
"The quality of research they have done for us has been excellent..."